多层包装的完整性怎么逐层验证

结论：先分清哪一层是无菌屏障，验证的重点就清楚了

医疗器械的包装通常有多层：与产品直接接触的初包装、外面的中包装、以及运输用的外箱。但不是每一层都承担同样的功能。

关键问题是：哪一层是无菌屏障？ 无菌屏障是那一层保证产品在使用前保持无菌的包装，它的完整性是无菌保证的核心。其他层主要起保护、便于操作、信息承载的作用。

分清之后，验证的重点就清楚了：无菌屏障层要做完整性验证，其他层做保护性能验证。 不分层次地对所有层做同样的验证，既浪费又可能漏掉重点。

各层的作用

注意无菌屏障不一定是最内层。 某些产品的最内层只是固定或分隔用的，真正的无菌屏障可能在外面一层。判断的依据是哪一层在开启前维持无菌状态。

完整性验证的方法

针对无菌屏障层，可用的方法有几类：

物理方法。 气泡法、真空衰减、压力衰减、示踪气体。这类方法能定量或半定量地检出泄漏。

染色渗透。 用染液检查密封处有无通道。直观，但对材料和密封形式有适用性限制。

目视检查。 检查明显的破损、皱褶、夹入物。最基础但必要。

微生物挑战。 用微生物气溶胶挑战包装，验证阻菌能力。这是最直接的验证，但操作复杂。

方法的选择要考虑： 包装的材料与形式（软包装、硬质、复合）；能检出的泄漏尺寸；是否破坏性；以及是否适合日常检验。

「能检出的泄漏尺寸」是选择方法的关键参数。 不同方法的灵敏度差别很大，而微生物能通过的通道尺寸是有量级的——方法的检出能力要与这个尺寸匹配，否则「未检出泄漏」说明不了问题。

阻隔性能的验证

除了有没有通道，材料本身的阻隔能力也要验证：

阻菌性能。 材料对微生物的阻挡能力。

透气性。 对于需要透气的包装（环氧乙烷灭菌用），透气性要足够。

水汽透过率。 对湿度敏感的产品。

氧气透过率。 对氧化敏感的产品。

光阻隔。 对光敏感的产品。

「透气性与阻菌性」是一对需要平衡的性能，透气性好的材料往往阻菌性差。专用的医用包装材料通过特殊的结构兼顾两者，普通材料一般做不到。

层间的相互影响

多层包装的各层不是独立的，相互影响包括：

外层保护内层。 外层的缓冲性能影响内层受到的冲击。

层间摩擦。 运输振动中层间摩擦可能磨损内层。

层间挤压。 堆码压力通过外层传递到内层。

水汽在层间的积累。 外层不透气时，层间可能积累水汽。

灭菌时的相互影响。 多层结构影响灭菌介质的穿透。

「层间摩擦磨损内层」是运输验证中会暴露的问题。 内层材料如果较薄，长时间振动下与外层或与产品摩擦，可能产生针孔。这类损伤从外观不易发现，需要用完整性检验方法确认。

取样与判据

取样量。 按失效后果的严重程度和统计要求确定。无菌屏障的取样量要求较高。

取样的代表性。 覆盖不同的生产批次、设备、班次。

判据的明确性。 什么算通过、什么算失败，事先定好。

边缘情况的处理。 检出微小泄漏但在方法的不确定度范围内时怎么判。

破坏性试验的样品预留。 完整性检验多数是破坏性的。

建议判据写成可直接判断的形式，比如「泄漏率低于某值」「染液未渗透至密封内缘」，而不是「密封完好」这类笼统表述。

与其他验证的关系

包装完整性验证不是孤立的，它与几项工作相关：

与灭菌验证。 灭菌过程对包装的影响，验证应当在灭菌后做。

与运输验证。 运输后的完整性是实际使用中的关键状态。

与稳定性研究。 货架期内完整性的保持。

与密封参数确认。 密封工艺窗口的确认是完整性的前提。

建议的验证顺序是： 密封参数窗口确认 → 灭菌后完整性 → 运输后完整性 → 货架期内的完整性。每一步都是在前一步的基础上增加考验。

日常生产的控制

在线检验。 部分方法可以在线或近线做。

抽检频次。 按风险和工艺稳定性确定。

目视检查。 每件都做，成本低但能发现明显问题。

趋势分析。 检验数据的趋势能提前发现工艺漂移。

异常处理。 出现不合格时的批次处理规定。

「趋势分析」的价值在于提前发现问题。 检验结果全部合格但泄漏率在逐步上升，说明工艺在漂移，这时调整比等到不合格再处理要主动得多。

保护层的验证

无菌屏障之外的各层，验证的重点是保护性能：

缓冲性能。 跌落和冲击时对内层的保护。

堆码强度。 仓储和运输中的抗压能力。

防潮防尘。 对内层的环境保护。

便于操作。 开启、分发、无菌操作的便利性。

标识的耐久。 运输和储存后标识是否仍清晰。

这些验证多数通过运输验证一并完成，不必单独设计一套试验。运输验证之后检查各层的状态，就能得到保护性能的信息。

材料变更的处理

包装材料变更是常见的变更类型，触发的验证包括：

密封参数窗口的重新确认。 新材料的热合特性可能不同。

完整性验证。 新材料的密封完整性。

阻隔性能验证。 阻菌、透气、水汽。

灭菌相容性。 新材料对灭菌过程的耐受。

运输验证。 保护性能是否等效。

稳定性。 货架期内的性能保持。

「同类材料替代」不能免除验证。 同样是某类薄膜，不同供应商、不同规格的热合窗口和阻隔性能可能差别明显。

我们的做法

做包装完整性验证时，我们会先与委托方确认哪一层是无菌屏障，因为这决定了验证的重点和方法的选择。 这一点不明确就开始测，容易在次要的层上花功夫。

方法选择上，我们会把方法的检出能力与关注的泄漏尺寸放在一起核对。检出能力不够的方法，测出来的合格结论支撑不了无菌保证。

如果你在做包装验证，不确定方法怎么选、取样怎么定，可以把包装结构和材料信息发过来一起讨论，或者直接联系：132 4819 8029。能力范围见服务介绍，流程见检测流程，更多内容见知识库。

English version

Conclusion. Medical device packaging usually has several layers: a primary pack in contact with the product, a secondary pack around it, and a shipper. Not every layer serves the same function. The key question is which layer forms the sterile barrier, meaning the layer that keeps the product sterile until use; its integrity is central to sterility assurance, while the others provide protection, handling convenience and information. Once that is clear, the focus of validation is clear: the sterile barrier layer requires integrity validation and the others require protective performance validation. Applying the same validation to every layer wastes effort and may still miss the point.

Roles of the layers. The primary pack, as sterile barrier, maintains sterility, and validation focuses on integrity, microbial barrier and sealing. The secondary pack protects, groups and carries information, and validation focuses on protective performance and marking. The shipper protects during transport and withstands stacking, and validation focuses on strength, cushioning and stacking. Cushioning components absorb shock, and validation focuses on cushioning performance and recovery. Note that the sterile barrier is not necessarily the innermost layer: in some products the innermost layer merely retains or separates, and the actual barrier lies further out. The test is which layer maintains sterility until opening.

Integrity test methods. Several categories apply to the sterile barrier layer. Physical methods, including bubble testing, vacuum decay, pressure decay and tracer gas, detect leaks quantitatively or semi-quantitatively. Dye penetration checks seals for channels, being direct while limited in applicability by material and seal form. Visual inspection checks for obvious damage, wrinkles and entrapped matter, being the most basic and still necessary. And microbial challenge using an aerosol verifies barrier performance directly, though the procedure is involved. Method selection must consider the packaging material and form, whether flexible, rigid or composite; the leak size detectable; whether the method is destructive; and whether it suits routine inspection. Detectable leak size is the key selection parameter: method sensitivities differ greatly, and the channel size through which microorganisms pass has a characteristic magnitude, so detection capability must match it or a no-leak-detected result proves nothing.

Barrier performance. Beyond the absence of channels, the material's own barrier capability requires verification. Microbial barrier performance covers the material's ability to exclude microorganisms. Permeability covers whether breathable packaging for ethylene oxide sterilisation is sufficiently permeable. Water vapour transmission matters for moisture-sensitive products. Oxygen transmission matters for oxidation-sensitive products. And light barrier matters for light-sensitive products. Permeability and microbial barrier must be balanced, since highly permeable materials tend to have poor barrier properties; purpose-made medical packaging materials reconcile the two through special construction, which ordinary materials generally cannot.

Interaction between layers. Layers are not independent. Outer layers protect inner ones, their cushioning determining the impact the inner layer experiences. Friction between layers during transport vibration can abrade the inner layer. Compression from stacking transmits through the outer layer to the inner. Water vapour can accumulate between layers where the outer layer is impermeable. And multilayer construction affects penetration of the sterilising agent. Abrasion of the inner layer by friction is a problem transport validation reveals: a thin inner layer rubbing against the outer layer or the product during prolonged vibration can develop pinholes, damage not readily visible and requiring integrity test methods to confirm.

Sampling and criteria. Sample size follows the severity of failure and statistical requirements, with sterile barrier work demanding more. Sampling must be representative across production batches, equipment and shifts. Criteria must be explicit as to what passes and what fails, set in advance. Borderline cases need a rule, covering what to do when a small leak is detected within the method's uncertainty. And samples must be reserved for destructive testing, since most integrity tests are destructive. Write criteria in directly judgeable form, such as leak rate below a stated value or dye not penetrating to the inner seal edge, rather than a general statement that the seal is intact.

Relationship to other validation. Packaging integrity does not stand alone. It relates to sterilisation validation, since sterilisation affects packaging and integrity should be assessed afterwards. It relates to transport validation, since post-transport integrity is the state that matters in use. It relates to stability studies, covering integrity retention across shelf life. And it relates to seal parameter validation, since the sealing process window underpins integrity. The suggested order is seal parameter window, then integrity after sterilisation, then after transport, then across shelf life, each step adding to the challenge of the last.

Production control. In-line or near-line inspection suits some methods. Sampling frequency follows risk and process stability. Visual inspection of every unit costs little and catches obvious problems. Trend analysis of inspection data reveals process drift early. And a rule must define batch handling when a failure occurs. Trend analysis is valuable for finding problems early: results all passing while leak rates climb steadily indicates drift, and adjusting then is far more proactive than waiting for a failure.

How we handle it. For packaging integrity work we confirm with the client which layer is the sterile barrier, since that determines the focus and method selection. Testing without settling it risks effort spent on secondary layers. On method selection we check detection capability against the leak size of concern, because a method of inadequate sensitivity produces a passing result that cannot support sterility assurance.

Send us the packaging construction and materials and we will work out methods and sampling. Phone or WeChat: +86 132 4819 8029.